“The AcRIS study is testing a mobile app to build a voice and symptom tool to help detect and monitor COVID-19 and other respiratory illnesses, like flu and RSV. Study participants complete voice recordings and report symptoms at home using their mobile device.”
Got that? Pfizer, via AcRIS, is building an app to test your voice samples for not only COVID-19 but also other illnesses such as the flu and pneumonia. What could possibly go wrong?
“You may be eligible for the AcRIS study if you:
- are relatively healthy,
- have not received any doses of a COVID-19 vaccine, and
- are willing to complete daily voice recordings and respiratory symptom reporting via a phone app for 6-8 weeks.”
Participants are encouraged to download the app and upload voice samples for six to eight weeks. They’re also sent two nasal swabs, of unknown origin, to test for any viruses they don’t know they have. Swabs are taken at home and mailed to AcRIS for whatever they’re doing with these samples.
Time will tell if voice technology will be able to detect viruses, much less the elusive COVID-19. For now, this “study” seems like a desperate attempt to gain more personal information from Americans while accumulating more “positive tests” to further the goal of mass vaccination.